Search by keywords: Upcoming Seminars and Events View upcoming seminars and events. Learn more 555 News Items found Memorial Sloan Kettering Cancer Center Applauds Highly Cited Researchers 2025 Wednesday, November 12, 2025 In 2025, MSK was again ranked among the top organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers, published by the Institute for Scientific Information at Clarivate. Training Tomorrow’s Leaders: Graduate Education at GSK Wednesday, November 12, 2025 Since its founding 19 years ago, the Gerstner Sloan Kettering Graduate School of Biomedical Sciences has attracted bright minds drawn to its connection to MSK. Learn more about how we're training tomorrow's leaders. MSK Researchers Make Strides Against VEXAS Syndrome Monday, November 3, 2025 VEXAS syndrome is a confounding adult-onset inflammatory disease first described in 2020, which affects 1 in 4,000 men over 50. Now, MSK researchers are shedding new light on its mechanisms and laying the groundwork for potential targeted treatments. MSK Research Highlights, September 25, 2025 Thursday, September 25, 2025 New MSK research highlights the importance of tumor location in metastasis; shows how regulatory T cells work with sensory nerves in the skin to restrain pain and inflammation; explores whether a large language model can adequately summarize cancer patients’ experiences with pain; and finds proton therapy is effective at treating leptomeningeal metastasis. 2025 GSK Chairman’s Prize Recognizes Research on DNA Double-Strand Breaks Wednesday, August 20, 2025 This year's GSK Chairman’s Prize was awarded to Zhi “Zack” Zheng for his research on the SPO11 protein, which creates double-strand breaks in DNA. MSK Research Highlights, August 8, 2025 Friday, August 8, 2025 New MSK research develops a powerful new resource for studying gene regulation across eukaryotes; uncovers how “jumping genes” can drive cancer growth; describes how an unexpected oxygen sensor regulates ferroptosis; establishes a technique to map chromatin architecture in 3D; creates new models for studying schizophrenia-associated defects; and finds transcription factor 19 is critical for the responses of natural killer cells to viral infection. How Cancer Spreads: Four Emerging Insights About Metastasis Thursday, July 10, 2025 Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis. High-Fructose Diet Harms Neurodevelopment and Leads to Anxiety in Mice, MSK Study Finds Wednesday, June 11, 2025 A new laboratory study from MSK is shedding light on the mechanisms by which high fructose consumption early in life may directly impact brain development and increase the risk of anxiety disorders later on. New Understanding of a Decades-Old Bladder Cancer Treatment Could Help Improve Immunotherapies More Broadly Thursday, May 29, 2025 A team of researchers from MSK and Weill Cornell Medicine is expanding the understanding of how a decades-old treatment for bladder cancer works — an understanding that could help improve the effectiveness of immunotherapies more broadly. MSK Research Highlights, May 19, 2025 Monday, May 19, 2025 New MSK research uncovers new details of the immune response against leptomeningeal metastasis; develops a grading system to assess the risk of developing thrombocytopenia after CAR T cell therapy; and outlines a method for scientists to estimate metabolic characteristics from challenging clinical samples. Pagination Load More